KARACHI: For the first time, a Chinese herbal medicine, traditionally used to cure bronchitis, will be accessible to Pakistani users after it successfully passed a year-long clinical trial at a research center in Pakistan and was declared suitable and effective for the residents of the South Asian state, reported Beijing’s official press agency Xinhua on Sunday.
Presenting the findings of the trial, Raza Shah, general manager of the Bioequivalence Studies and Clinical Research at the International Center for Chemical and Biological Sciences (ICCBS) of the University of Karachi, said that Amoxicillin, an antibiotic widely used to cure bronchitis, was “losing its potency against bacteria due to resistance, so there was a need for alternate and Yinhuang Qingfei [the Chinese capsule] proved to be a good alternative.”
Chronic bronchitis is a common disease related to chronic inflammation, which is caused by a variety of pathogenic factors, such as air pollution, smoking, and pathogen infection.
A total of 212 patients were treated during the trial period and the effectiveness against cough rate in case of Yinhuang Qingfei was 72.8 percent and that of antibiotic Amoxicillin-Clavulanate was 71.8 percent, the report said.
It may be recalled that Pakistan and China signed a joint statement in November 2018, agreeing to enhance cooperation in the field of traditional medicine.